![New drug treatments versus structured education programmes for type 2 diabetes: comparing cost-effectiveness - The Lancet Diabetes & Endocrinology New drug treatments versus structured education programmes for type 2 diabetes: comparing cost-effectiveness - The Lancet Diabetes & Endocrinology](https://www.thelancet.com/cms/attachment/cb8b8a19-b76e-4185-a5c1-ea3dcdf4e1ce/gr1_lrg.jpg)
New drug treatments versus structured education programmes for type 2 diabetes: comparing cost-effectiveness - The Lancet Diabetes & Endocrinology
![Cost‐effectiveness analysis of empagliflozin treatment in people with Type 2 diabetes and established cardiovascular disease in the EMPA‐REG OUTCOME trial - Kansal - 2019 - Diabetic Medicine - Wiley Online Library Cost‐effectiveness analysis of empagliflozin treatment in people with Type 2 diabetes and established cardiovascular disease in the EMPA‐REG OUTCOME trial - Kansal - 2019 - Diabetic Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/5bdf750b-4d6f-4f25-a4c9-aeb72cc249ab/dme.v36.11.cover.jpg)
Cost‐effectiveness analysis of empagliflozin treatment in people with Type 2 diabetes and established cardiovascular disease in the EMPA‐REG OUTCOME trial - Kansal - 2019 - Diabetic Medicine - Wiley Online Library
![Trends in the management of type 2 diabetes and its prescription drug costs in Greece (2006 and 2012) - Media Centre | EASD Trends in the management of type 2 diabetes and its prescription drug costs in Greece (2006 and 2012) - Media Centre | EASD](https://d2t0unnjxes6lt.cloudfront.net/data/easd/data/eposters/480_592341/slide1.jpg)
Trends in the management of type 2 diabetes and its prescription drug costs in Greece (2006 and 2012) - Media Centre | EASD
![Distribution of costs in patients with type 2 diabetes mellitus: a retrospective claims database analysis - Media Centre | EASD Distribution of costs in patients with type 2 diabetes mellitus: a retrospective claims database analysis - Media Centre | EASD](https://d2t0unnjxes6lt.cloudfront.net/data/easd/data/eposters/480_592921_1/slide1.jpg)
Distribution of costs in patients with type 2 diabetes mellitus: a retrospective claims database analysis - Media Centre | EASD
![Economic Burden of Type 2 Diabetes Mellitus: Direct cost, Indirect cost and Nutritional Cost of Type 2 Diabetes Mellitus in a selected Bangladeshi population: Afroz, Afsana: 9783659153044: Amazon.com: Books Economic Burden of Type 2 Diabetes Mellitus: Direct cost, Indirect cost and Nutritional Cost of Type 2 Diabetes Mellitus in a selected Bangladeshi population: Afroz, Afsana: 9783659153044: Amazon.com: Books](https://m.media-amazon.com/images/I/41TwyxC84KL._AC_SY780_.jpg)
Economic Burden of Type 2 Diabetes Mellitus: Direct cost, Indirect cost and Nutritional Cost of Type 2 Diabetes Mellitus in a selected Bangladeshi population: Afroz, Afsana: 9783659153044: Amazon.com: Books
![UK Health Security Agency a Twitteren: "Type 2 diabetes treatment accounts for just under 9% of the annual NHS budget. This is around £8.8 billion a year. Find out more here: https://t.co/BV0hCYpCgh # UK Health Security Agency a Twitteren: "Type 2 diabetes treatment accounts for just under 9% of the annual NHS budget. This is around £8.8 billion a year. Find out more here: https://t.co/BV0hCYpCgh #](https://pbs.twimg.com/media/DeB0ODgVQAABtgg.png)
UK Health Security Agency a Twitteren: "Type 2 diabetes treatment accounts for just under 9% of the annual NHS budget. This is around £8.8 billion a year. Find out more here: https://t.co/BV0hCYpCgh #
![Components of total cost of Type 2 diabetes Percentages represent the... | Download Scientific Diagram Components of total cost of Type 2 diabetes Percentages represent the... | Download Scientific Diagram](https://www.researchgate.net/publication/280352458/figure/fig1/AS:306893068226560@1450180417957/Components-of-total-cost-of-Type-2-diabetes-Percentages-represent-the-mid-point-of-the.png)
Components of total cost of Type 2 diabetes Percentages represent the... | Download Scientific Diagram
![Costs of diabetes complications: hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden - IHE Costs of diabetes complications: hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden - IHE](http://ihe.se/wp-content/uploads/2020/09/Diabetes.jpg)
Costs of diabetes complications: hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden - IHE
![Within-trial cost and 1-year cost-effectiveness of the DiRECT/Counterweight-Plus weight-management programme to achieve remission of type 2 diabetes - The Lancet Diabetes & Endocrinology Within-trial cost and 1-year cost-effectiveness of the DiRECT/Counterweight-Plus weight-management programme to achieve remission of type 2 diabetes - The Lancet Diabetes & Endocrinology](https://www.thelancet.com/cms/attachment/61c81312-da77-4e05-85d2-731817205913/gr1_lrg.jpg)
Within-trial cost and 1-year cost-effectiveness of the DiRECT/Counterweight-Plus weight-management programme to achieve remission of type 2 diabetes - The Lancet Diabetes & Endocrinology
![Costs of diabetes complications: hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden | SpringerLink Costs of diabetes complications: hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00125-020-05277-3/MediaObjects/125_2020_5277_Figa_HTML.png)
Costs of diabetes complications: hospital-based care and absence from work for 392,200 people with type 2 diabetes and matched control participants in Sweden | SpringerLink
![The costs of diabetes treatment in low- and middle-income countries: a systematic review | BMJ Global Health The costs of diabetes treatment in low- and middle-income countries: a systematic review | BMJ Global Health](https://gh.bmj.com/content/bmjgh/4/1/e001258/F3.large.jpg)